← Leaderboards
Mark Ettenhofer
Neurofit, Inc.
$1,014,213
Attributed
$2,889,836
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,889,836 · 2
By mechanism
R44$2,584,232 · 1
R43$305,604 · 1
Top collaborators
- Daniel A Nation2 shared
- Sarka Olivera Southern2 shared
- Dorion Bryce Liston1 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposTechnologyDevicesRaceSmall Business Innovation Research GrantStandardizationNeurocognitiveMild Cognitive ImpairmentNeuropsychologyPrototypeScreeningS DiseaseSamplingBiological MarkersDementiaDesignDiagnosisDisease ProgressionBurden Of IllnessAmericanCognitivePathway InteractionsCostTraining
Grant awards (3)
Rapid saliva test for noninvasive diagnostic screening of MCI and dementia$1,302,154
R44 · FY2023 · AG
Rapid saliva test for noninvasive diagnostic screening of MCI and dementia$1,282,078
R44 · FY2022 · AG
Development of Neurocognitive Eye Tracking for Rapid Screening of Mild Cognitive Impairment$305,604
R43 · FY2019 · AG